SZ-A, the extract of Morus alba L., has been shown to reduce hyperglycemia in patients [24] and was approved for T2DM treatment in 2020, including the regulation of α-glucosidases, insulin sensitivity, microbiota, and inflammation. This evidence concerns the gene INS and Hyperglycemia.